STRATA Skin Sciences announced that it had been notified by Nasdaq that Strata has regained compliance with the Nasdaq listing requirements regarding minimum bid price, Rule 5550.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SSKN:
- STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Inaugural Winter Clinical Conference
- Strata Skin Sciences sees 2022 revenue $35M-$36M, consensus $34.35M
- STRATA Skin Sciences Announces Poster Accepted at ODAC Dermatology, Aesthetic & Surgical Conference
- Strata Skin Sciences announces poster presentation on photopneumatic therapy
- STRATA Skin Sciences Expands into $300 Million Market with Exclusive Distribution Agreement in Mexico